PKC-mediated modulation of L-type calcium channels may contribute to fat-induced insulin resistance

Medical Hypotheses

Volumn 66, Issue 4, 2006, Pages 824-831

  McCarty, Mark F ^a  

^a Natural Alternatives International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CALCIUM CHANNEL L TYPE; CHROMIUM PICOLINATE; DIACYLGLYCEROL; FATTY ACID; INSULIN RECEPTOR SUBSTRATE 1; MAGNESIUM; PARATHYROID HORMONE; PROTEIN KINASE C; VITAMIN D;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM ANTAGONISM; CALCIUM INTAKE; CALCIUM TRANSPORT; CONDUCTANCE; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MOUSE; NONHUMAN; OBESITY; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; RISK; SECONDARY HYPERPARATHYROIDISM; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; UPREGULATION;

ANIMALS; CALCIUM; CALCIUM CHANNELS, L-TYPE; CHROMIUM; DIETARY FATS; HYPERPARATHYROIDISM; INSULIN RESISTANCE; MAGNESIUM; MUSCLE, SKELETAL; PROTEIN KINASE C; RATS; UP-REGULATION;

ANIMALIA; RODENTIA;

EID: 31844440577     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.08.034     Document Type: Article

References (118)

1. L.M. Resnick, R.K. Gupta, K.K. Bhargava, H. Gruenspan, M.H. Alderman, and J.H. Laragh Cellular ions in hypertension, diabetes, and obesity. A nuclear magnetic resonance spectroscopic study Hypertension 17 1991 951 957
2. L.M. Resnick Cellular ions in hypertension, insulin resistance, obesity, and diabetes: a unifying theme J Am Soc Nephrol 3 1992 S78 S85
3. R.L. Byyny, M. LoVerde, S. Lloyd, W. Mitchell, and B. Draznin Cytosolic calcium and insulin resistance in elderly patients with essential hypertension Am J Hypertens 5 1992 459 464
4. B. Draznin Cytosolic calcium and insulin resistance Am J Kidney Dis 21 1993 32 38
5. S. Sela, R. Shurtz-Swirski, R. Farah, R. Levy, G. Shapiro, and J. Chezar A link between polymorphonuclear leukocyte intracellular calcium, plasma insulin, and essential hypertension Am J Hypertens 15 2002 291 295
6. Y. Fu, S. Wang, and Z. Lu The relationship between insulin resistance and abnormalities of cellular calcium metabolism and cell membrane abnormalities in patients with essential hypertension Zhonghua Yi Xue Za Zhi 77 1997 443 446
7. P. Erne, P. Bolli, E. Burgisser, and F.R. Buhler Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy New Engl J Med 310 1984 1084 1088
8. B. Draznin, K. Sussman, M. Kao, D. Lewis, and N. Sherman The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes J Biol Chem 262 1987 14385 14388
9. B. Draznin, K.E. Sussman, R.H. Eckel, M. Kao, T. Yost, and N.A. Sherman Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia J Clin Invest 82 1988 1848 1852
10. B. Draznin, D. Lewis, N. Houlder, N. Sherman, M. Adamo, and W.T. Garvey Mechanism of insulin resistance induced by sustained levels of cytosolic free calcium in rat adipocytes Endocrinology 125 1989 2341 2349
11. J.E. Reusch, N. Begum, K.E. Sussman, and B. Draznin Regulation of GLUT-4 phosphorylation by intracellular calcium in adipocytes Endocrinology 129 1991 3269 3273
12. N. Begum, K.E. Sussman, and B. Draznin Calcium-induced inhibition of phosphoserine phosphatase in insulin target cells is mediated by the phosphorylation and activation of inhibitor 1 J Biol Chem 267 1992 5959 5963
13. N. Begum, W. Leitner, J.E. Reusch, K.E. Sussman, and B. Draznin GLUT-4 phosphorylation and its intrinsic activity. Mechanism of Ca (2+)-induced inhibition of insulin-stimulated glucose transport J Biol Chem 268 1993 3352 3356
14. P. Dent, A. Lavoinne, S. Nakielny, F.B. Caudwell, P. Watt, and P. Cohen The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle Nature 348 1990 302 308
15. M. Srinivasan, and N. Begum Regulation of protein phosphatase 1 and 2A activities by insulin during myogenesis in rat skeletal muscle cells in culture J Biol Chem 269 1994 12514 12520
16. L. Ragolia, and N. Begum The effect of modulating the glycogen-associated regulatory subunit of protein phosphatase-1 on insulin action in rat skeletal muscle cells Endocrinology 138 1997 2398 2404
17. N.A. Syed, and R.L. Khandelwal Reciprocal regulation of glycogen phosphorylase and glycogen synthase by insulin involving phosphatidylinositol-3 kinase and protein phosphatase-1 in HepG2 cells Mol Cell Biochem 211 2000 123 136
18. M.B. Zemel, J.H. Kim, R.P. Woychik, E.J. Michaud, S.H. Kadwell, and I.R. Patel Agouti regulation of intracellular calcium: role in the insulin resistance of viable yellow mice Proc Natl Acad Sci USA 92 1995 4733 4737
19. M.B. Zemel Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insulin resistance and hypertension Mol Cell Biochem 188 1998 129 136
20. Y.J. Jang, H.J. Ryu, Y.O. Choi, C. Kim, C.H. Leem, and C.S. Park Improvement of insulin sensitivity by chelation of intracellular Ca(2+) in high-fat-fed rats Metabolism 51 2002 912 918
21. Y.J. Jang, H.J. Ryu, Y.O. Choi, J.G. Lee, C. Kim, and C.H. Leem Effects of an intracellular Ca (2+) chelator on insulin resistance and hypertension in high-fat-fed rats and spontaneously hypertensive rats Metabolism 53 2004 269 272
22. M. Krssak, P.K. Falk, A. Dresner, L. DiPietro, S.M. Vogel, and D.L. Rothman Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study Diabetologia 42 1999 113 116
23. G. Perseghin, P. Scifo, F. De Cobelli, E. Pagliato, A. Battezzati, and C. Arcelloni Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents Diabetes 48 1999 1600 1606
24. N.G. Forouhi, G. Jenkinson, E.L. Thomas, S. Mullick, S. Mierisova, and U. Bhonsle Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men Diabetologia 42 1999 932 935
25. R. Sinha, S. Dufour, K.F. Petersen, V. LeBon, S. Enoksson, and Y.Z. Ma Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity Diabetes 51 2002 1022 1027
26. K.F. Petersen, S. Dufour, D. Befroy, R. Garcia, and G.I. Shulman Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes New Engl J Med 350 2004 664 671
27. C. Schmitz-Peiffer, C.L. Browne, N.D. Oakes, A. Watkinson, D.J. Chisholm, and E.W. Kraegen Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat Diabetes 46 1997 169 178
28. C. Yu, Y. Chen, G.W. Cline, D. Zhang, H. Zong, and Y. Wang Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle J Biol Chem 277 2002 50230 50236
29. C. Schmitz-Peiffer Protein kinase C and lipid-induced insulin resistance in skeletal muscle Ann N Y Acad Sci 967 2002 146 157
30. S.I. Itani, N.B. Ruderman, F. Schmieder, and G. Boden Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha Diabetes 51 2002 2005 2011
31. G. Boden, and L.H. Carnell Nutritional effects of fat on carbohydrate metabolism Best Pract Res Clin Endocrinol Metab 17 2003 399 410
32. J.K. Kim, Y.J. Kim, J.J. Fillmore, Y. Chen, I. Moore, and J. Lee Prevention of fat-induced insulin resistance by salicylate J Clin Invest 108 2001 437 446
33. M. Yuan, N. Konstantopoulos, J. Lee, L. Hansen, Z.W. Li, and M. Karin Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta Science 293 2001 1673 1677
34. R.S. Hundal, K.F. Petersen, A.B. Mayerson, P.S. Randhawa, S. Inzucchi, and S.E. Shoelson Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes J Clin Invest 109 2002 1321 1326
35. Z. Gao, D. Hwang, F. Bataille, M. Lefevre, D. York, and M.J. Quon Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex J Biol Chem 277 2002 48115 48121
36. S.E. Shoelson, J. Lee, and M. Yuan Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance Int J Obes Relat Metab Disord 27 Suppl. 3 2003 S49 S52
37. V. Aguirre, T. Uchida, L. Yenush, R. Davis, and M.F. White The c-Jun NH (2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser (307) J Biol Chem 275 2000 9047 9054
38. J. Hirosumi, G. Tuncman, L. Chang, C.Z. Gorgun, K.T. Uysal, and K. Maeda A central role for JNK in obesity and insulin resistance Nature 420 2002 333 336
39. B.L. Bennett, Y. Satoh, and A.J. Lewis JNK: a new therapeutic target for diabetes Curr Opin Pharmacol 3 2003 420 425
40. T.L. Hilder, J.C. Tou, R.E. Grindeland, C.E. Wade, and L.M. Graves Phosphorylation of insulin receptor substrate-1 serine 307 correlates with JNK activity in atrophic skeletal muscle FEBS Lett 553 2003 63 67
41. G. Jiang, Q. Dallas-Yang, F. Liu, D.E. Moller, and B.B. Zhang Salicylic acid reverses phorbol 12-myristate-13-acetate (PMA)- and tumor necrosis factor alpha (TNFalpha)-induced insulin receptor substrate 1 (IRS1) serine 307 phosphorylation and insulin resistance in human embryonic kidney 293 (HEK293) cells J Biol Chem 278 2003 180 186
42. G.S. Hotamisligil Inflammatory pathways and insulin action Int J Obes Relat Metab Disord 27 Suppl. 3 2003 S53 S55
43. C.F. Chang, L.M. Gutierrez, C. Mundina-Weilenmann, and M.M. Hosey Dihydropyridine-sensitive calcium channels from skeletal muscle. II. Functional effects of differential phosphorylation of channel subunits J Biol Chem 266 1991 16395 16400
44. T.F. McDonald, S. Pelzer, W. Trautwein, and D.J. Pelzer Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells Physiol Rev 74 1994 365 507
45. O. Delbono, M. Renganathan, and M.L. Messi Regulation of mouse skeletal muscle L-type Ca2+ channel by activation of the insulin-like growth factor-1 receptor J Neurosci 17 1997 6918 6928
46. D.A. Capiati, G. Vazquez, M.T. Tellez Inon, and R.L. Boland Role of protein kinase C in 1,25 (OH) (2)-vitamin D (3) modulation of intracellular calcium during development of skeletal muscle cells in culture J Cell Biochem 77 2000 200 212
47. K. Masuo, H. Mikami, T. Ogihara, and M.L. Tuck Metabolic effects of long-term treatments with nifedipine-retard and captopril in young hypertensive patients Am J Hypertens 10 1997 600 610
48. I. Kosegawa, M. Inaba, T. Morita, T. Awata, and S. Katayama Effect of the vasodilatory beta-blocker, nipradilol, and Ca-antagonist, barnidipine, on insulin sensitivity in patients with essential hypertension Clin Exp Hypertens 20 1998 751 761
49. D. Lender, C. Arauz-Pacheco, L. Breen, P. Mora-Mora, L.C. Ramirez, and P. Raskin A double blind comparison of the effects of amlodipine and enalapril on insulin sensitivity in hypertensive patients Am J Hypertens 12 1999 298 303
50. E. Bonora, G. Targher, M. Alberiche, R.C. Bonadonna, F. Saggiani, and M.B. Zenere Effect of chronic treatment with lacidipine or lisinopril on intracellular partitioning of glucose metabolism in type 2 diabetes mellitus J Clin Endocrinol Metab 84 1999 1544 1550
51. M. Suzuki, A. Kanazawa, M. Hasegawa, and Y. Harano Improvement of insulin resistance in essential hypertension by long-acting Ca antagonist benidipine Clin Exp Hypertens 21 1999 1327 1344
52. J. Lin, D. Czhen, and K. Wu The effect of amlodipine, nifedipine and perindopril on insulin sensitivity and blood lipid of patients with essential hypertension Zhonghua Yi Xue Za Zhi 78 1998 200 202
53. Y. Koyama, K. Kodama, M. Suzuki, and Y. Harano Improvement of insulin sensitivity by a long-acting nifedipine preparation (nifedipine-CR) in patients with essential hypertension Am J Hypertens 15 2002 927 931
54. S. Yagi, S. Goto, T. Yamamoto, S. Kurihara, and S. Katayama Effect of cilnidipine on insulin sensitivity in patients with essential hypertension Hypertens Res 26 2003 383 387
55. M.S. Gokhale, D.H. Shah, Z. Hakim, D.D. Santani, and R.K. Goyal Effect of chronic treatment with amlodipine in non-insulin-dependent diabetic rats Pharmacol Res 37 1998 455 459
56. A.A. Mehta, S. Patel, D.D. Santani, and R.K. Goyal Effect of nifedipine and enalapril on insulin-induced glucose disposal in spontaneous hypertensive and diabetic rats Clin Exp Hypertens 21 1999 51 59
57. M. Pitre, N. Gaudreault, M. Santure, A. Nadeau, and H. Bachelard Isradipine and insulin sensitivity in hypertensive rats Am J Physiol 276 1999 E1038 E1048
58. N. Harada, M. Ohnaka, S. Sakamoto, Y. Niwa, and Y. Nakaya Cilnidipine improves insulin sensitivity in the Otsuka Long-Evans Tokushima fatty rat, a model of spontaneous NIDDM Cardiovasc Drugs Ther 13 1999 519 523
59. C. Berne, T. Pollare, and H. Lithell Effects of antihypertensive treatment on insulin sensitivity with special reference to ACE inhibitors Diabetes Care 14 Suppl. 4 1991 39 47
60. L. Lind, C. Berne, T. Pollare, and H. Lithell Metabolic effects of anti-hypertensive treatment with nifedipine or furosemide: a double-blind, cross-over study J Hum Hypertens 9 1995 137 141
61. H.O. Lithell Hyperinsulinemia, insulin resistance, and the treatment of hypertension Am J Hypertens 9 1996 150S 154S
62. S. Segal, S. Lloyd, N. Sherman, K. Sussman, and B. Draznin Postprandial changes in cytosolic free calcium and glucose uptake in adipocytes in obesity and non-insulin-dependent diabetes mellitus Horm Res 34 1990 39 44
63. C. Qi, and P.H. Pekala Tumor necrosis factor-alpha-induced insulin resistance in adipocytes Proc Soc Exp Biol Med 223 2000 128 135
64. Y. Uchida, K. Ohba, A. Ogawa, K. Wada, T. Yoshioka, and T. Muraki Protein kinase C mediates tumor necrosis factor-alpha-induced inhibition of obese gene expression and leptin secretion in brown adipocytes Naunyn Schmiedebergs Arch Pharmacol 360 1999 691 698
65. H.H. Zhang, M. Halbleib, F. Ahmad, V.C. Manganiello, and A.S. Greenberg Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP Diabetes 51 2002 2929 2935
66. R. Baczynski, S.G. Massry, M. Magott, S. el Belbessi, R. Kohan, and N. Brautbar Effect of parathyroid hormone on energy metabolism of skeletal muscle Kidney Int 28 1985 722 727
67. Z. Ni, M. Smogorzewski, and S.G. Massry Effects of parathyroid hormone on cytosolic calcium of rat adipocytes Endocrinology 135 1994 1837 1844
68. P. Urena, X.F. Kong, A.B. Abou-Samra, H. Juppner, H.M. Kronenberg, and J.T. Potts Jr. Parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues Endocrinology 133 1993 617 623
69. H. Schneider, J.H. Feyen, and K. Seuwen A C-terminally truncated human parathyroid hormone receptor is functional and activates multiple G proteins FEBS Lett 351 1994 281 285
70. R. Prager, G. Schernthaner, B. Niederle, and R. Roka Evaluation of glucose tolerance, insulin secretion, and insulin action in patients with primary hyperparathyroidism before and after surgery Calcif Tissue Int 46 1990 1 4
71. A. Kautzky-Willer, G. Pacini, B. Niederle, G. Schernthaner, and R. Prager Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery Clin Endocrinol (Oxf) 37 1992 147 155
72. S. Kumar, A.O. Olukoga, C. Gordon, E.B. Mawer, M. France, and J.P. Hosker Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism Clin Endocrinol (Oxf) 40 1994 47 53
73. A. Kautzky-Willer, G. Pacini, U. Barnas, B. Ludvik, C. Streli, and H. Graf Intravenous calcitriol normalizes insulin sensitivity in uremic patients Kidney Int 47 1995 200 206
74. M. Procopio, and G. Borretta Derangement of glucose metabolism in hyperparathyroidism J Endocrinol Invest 26 2003 1136 1142
75. G.A. MacGregor, and F.P. Cappuccio The kidney and essential hypertension: a link to osteoporosis? J Hypertens 11 1993 781 785
76. M. Sanchez, A. de la Sierra, A. Coca, E. Poch, V. Giner, and A. Urbano-Marquez Oral calcium supplementation reduces intraplatelet free calcium concentration and insulin resistance in essential hypertensive patients Hypertension 29 1997 531 536
77. G.A. Colditz, J.E. Manson, M.J. Stampfer, B. Rosner, W.C. Willett, and F.E. Speizer Diet and risk of clinical diabetes in women Am J Clin Nutr 55 1992 1018 1023
78. M.A. Pereira, D.R.J. Jacobs, L. Van Horn, M.L. Slattery, A.I. Kartashov, and D.S. Ludwig Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA study JAMA 287 2002 2081 2089
79. K.C. Chiu, A. Chu, V.L. Go, and M.F. Saad Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction Am J Clin Nutr 79 2004 820 825
80. K.C. Chiu, L.M. Chuang, N.P. Lee, J.M. Ryu, J.L. McGullam, and G.P. Tsai Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level Metabolism 49 2000 1501 1505
81. A.I. Gunal, H. Celiker, H. Celebi, B. Ustundag, and S.Y. Gunal Intravenous alfacalcidol improves insulin resistance in hemodialysis patients Clin Nephrol 48 1997 109 113
82. H.M. Perry, M. Horowitz, S. Fleming, F.E. Kaiser, P. Patrick, and J.E. Morley Effect of recent alcohol intake on parathyroid hormone and mineral metabolism in men Alcohol Clin Exp Res 22 1998 1369 1375
83. H.M. Perry, M. Horowitz, S. Fleming, F.E. Kaiser, P. Patrick, and J.E. Morley The effects of season and alcohol intake on mineral metabolism in men Alcohol Clin Exp Res 23 1999 214 219
84. P.B. Rapuri, J.C. Gallagher, K.E. Balhorn, and K.L. Ryschon Alcohol intake and bone metabolism in elderly women Am J Clin Nutr 72 2000 1206 1213
85. M.F. McCarty, and C.A. Thomas PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight Med Hypotheses 61 2003 535 542
86. H. Shi, A.W. Norman, W.H. Okamura, A. Sen, and M.B. Zemel 1Alpha, 25-dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action FASEB J 15 2001 2751 2753
87. M.B. Zemel, H. Shi, B. Greer, D. Dirienzo, and P.C. Zemel Regulation of adiposity by dietary calcium FASEB J 14 2000 1132 1138
88. R.P. Heaney, K.M. Davies, and M.J. Barger-Lux Calcium and weight: clinical studies J Am Coll Nutr 21 2002 152S 155S
89. i) inhibition of lipolysis in human adipocytes FASEB J 15 2001 2527 2529
90. M.B. Zemel Mechanisms of dairy modulation of adiposity J Nutr 133 2003 252S 256S
91. R. Vieth Simple method for determining specific binding capacity of vitamin D-binding protein and its use to calculate the concentration of "free" 1,25-dihydroxyvitamin D Clin Chem 40 1994 435 441
92. A. Preston, and J.M. Haynes Alpha 1-adrenoceptor effects mediated by protein kinase C alpha in human cultured prostatic stromal cells Br J Pharmacol 138 2003 218 224
93. M.F. McCarty Elevated sympathetic activity may promote insulin resistance syndrome by activating alpha-1 adrenergic receptors on adipocytes Med Hypotheses 62 2004 830 838
94. L.M. Resnick, R.K. Gupta, H. Gruenspan, and J.H. Laragh Intracellular free magnesium in hypertension: relation to peripheral insulin resistance J Hypertens Suppl 6 1988 S199 S201
95. S. Humphries, H. Kushner, and B. Falkner Low dietary magnesium is associated with insulin resistance in a sample of young, nondiabetic Black Americans Am J Hypertens 12 1999 747 756
96. A.D. Liese, A.K. Roach, K.C. Sparks, L. Marquart, R.B. D'Agostino Jr., and E.J. Mayer-Davis Whole-grain intake and insulin sensitivity: the insulin resistance atherosclerosis study Am J Clin Nutr 78 2003 965 971
97. T.T. Fung, J.E. Manson, C.G. Solomon, S. Liu, W.C. Willett, and F.B. Hu The association between magnesium intake and fasting insulin concentration in healthy middle-aged women J Am Coll Nutr 22 2003 533 538
98. C.Y. Yang, H.F. Chiu, M.F. Cheng, S.S. Tsai, C.F. Hung, and Y.T. Tseng Magnesium in drinking water and the risk of death from diabetes mellitus Magnes Res 12 1999 131 137
99. N.M. McKeown, J.B. Meigs, S. Liu, P.W. Wilson, and P.F. Jacques Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the framingham offspring study Am J Clin Nutr 76 2002 390 398
100. T.T. Fung, F.B. Hu, M.A. Pereira, S. Liu, M.J. Stampfer, and G.A. Colditz Whole-grain intake and the risk of type 2 diabetes: a prospective study in men Am J Clin Nutr 76 2002 535 540
101. Y. Song, J.E. Manson, J.E. Buring, and S. Liu Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women Diabetes Care 27 2004 59 65
102. R. Lopez-Ridaura, W.C. Willett, E.B. Rimm, S. Liu, M.J. Stampfer, and J.E. Manson Magnesium intake and risk of type 2 diabetes in men and women Diabetes Care 27 2004 134 140
103. M.L. Lima, T. Cruz, J.C. Pousada, L.E. Rodrigues, K. Barbosa, and V. Cangucu The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes Diabetes Care 21 1998 682 686
104. M. Rodriguez-Moran, and F. Guerrero-Romero Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial Diabetes Care 26 2003 1147 1152
105. T.W. Balon, A. Jasman, S. Scott, W.P. Meehan, R.K. Rude, and J.L. Nadler Dietary magnesium prevents fructose-induced insulin insensitivity in rats Hypertension 23 1994 1036 1039
106. T.W. Balon, J.L. Gu, Y. Tokuyama, A.P. Jasman, and J.L. Nadler Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM Am J Physiol 269 1995 E745 E752
107. M.F. McCarty Magnesium may mediate the favorable impact of whole grains on insulin sensitivity by acting as a mild calcium antagonist Med Hypotheses 64 2005 619 627
108. M. Wang, M. Tashiro, and J.R. Berlin Regulation of L-type calcium current by intracellular magnesium in rat cardiac myocytes J Physiol 555 2004 383 396
109. B.M. Altura, A. Zhang, T.P. Cheng, and B.T. Altura Extracellular magnesium regulates nuclear and perinuclear free ionized calcium in cerebral vascular smooth muscle cells: possible relation to alcohol and central nervous system injury Alcohol 23 2001 83 90
110. M. Shechter, C.N. Merz, M. Paul-Labrador, S.R. Meisel, R.K. Rude, and M.D. Molloy Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease Am J Cardiol 84 1999 152 156
111. R.A. Anderson, N. Cheng, N.A. Bryden, M.M. Polansky, N. Cheng, and J. Chi Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes Diabetes 46 1997 1786 1791
112. D.S. Kim, T.W. Kim, I.K. Park, J.S. Kang, and A.S. Om Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body weight in dexamethasone-treated rats Metabolism 51 2002 589 594
113. W.T. Cefalu, Z.Q. Wang, X.H. Zhang, L.C. Baldor, and J.C. Russell Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats J Nutr 132 2002 1107 1114
114. D. Ghosh, B. Bhattacharya, B. Mukherjee, B. Manna, M. Sinha, and J. Chowdhury Role of chromium supplementation in Indians with type 2 diabetes mellitus J Nutr Biochem 13 2002 690 697
115. M.F. McCarty Chromium meta-analysis Am J Clin Nutr 78 2003 191 192
116. D.S. Kim, T.W. Kim, and J.S. Kang Chromium picolinate supplementation improves insulin sensitivity in Goto-Kakizaki diabetic rats J Trace Elem Med Biol 17 2004 243 247
117. J.W. Moore, M.A. Maher, W.J. Banz, and M.B. Zemel Chromium picolinate modulates rat vascular smooth muscle cell intracellular calcium metabolism J Nutr 128 1998 180 184
118. N.A. Lee, and C.A. Reasner Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM Diabetes Care 17 1994 1449 1452